May cause dizziness — Label Decoder

Official label information

In labeled postherpetic neuralgia trials, dizziness occurred in 28% of Neurontin-treated patients versus 8% with placebo and was a common reason for stopping. Epilepsy trials also reported dizziness and ataxia more often than placebo.

Plain-language explanation

Dizziness can mean lightheadedness, spinning, or feeling unsteady, and it can increase fall risk. Getting up slowly and asking for help when needed may be discussed with a clinician.

What this often means for gabapentin products

Dizziness raises fall risk, especially in older adults. Rising slowly may be discussed with a clinician; it is not a substitute for asking whether the product, other sedatives, or dehydration is contributing.

Ask your pharmacist

Ask what symptoms distinguish a common mild effect from one that needs prompt evaluation.

Caution: A fall, fainting, severe dizziness, or sudden new neurologic symptoms needs timely medical assessment.

Sources

DailyMed: NEURONTIN (gabapentin) capsules, tablets, and oral solution — U.S. National Library of Medicine

This decoder does not diagnose, set a personal dose, or create a taper schedule. If two instructions conflict, pause and ask the dispensing pharmacist.